Estimating the Prevalence of Alzheimer's Disease Pathology Using Plasma Biomarkers in COMPASS‐ND
The plasma biomarkers assays tested have high specificity for detecting AD pathology, enabling their use to estimate AD pathology in a larger cohort. Based on the low sensitivity of the plasma biomarkers tested, we assume that these results underestimate the prevalence of AD pathology in the COMPASS-ND cohort.
Authors
- David H. Yang (ORCID: https://orcid.org/0000-0001-8755-1101)
- Johnny W. Huang (ORCID: https://orcid.org/0000-0002-8380-0366)
- Sophie Stukas (ORCID: https://orcid.org/0000-0001-8819-8821)
- Cheryl L. Wellington (ORCID: https://orcid.org/0000-0001-7014-039X)
- Mari L. DeMarco
- Bruna Seixas Lima
- Durjoy Lahiri
- Nyra Ahmed
- Howard Chertkow
- Jennifer G Cooper
Institutions
- University of British Columbia (CA)
- University of Toronto (CA)
- Queen's University (CA)
- Baycrest Hospital (CA)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_103330
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00